In stable patients without heart failure, discontinuing beta-blockers 1 year after a heart attack was noninferior to ...

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

The SMART-DECISION trial has found that in stabilized patients after myocardial infarction (MI) without heart failure or left ventricular systolic dysfunction, discontinuing beta-blockers after one ...

Researchers from the Icahn School of Medicine at Mount Sinai in New York have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity-a ...

For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help ...

The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.

Trial assessed outcomes of quitting therapy after 1 year among select MI survivors ...

There is no data to support the worry that beta blockers, prescribed following a heart attack to guard against future episodes, commonly cause depression, fatigue and sexual dysfunction, according to ...

MADRID — Taken together, two new randomized trials and a meta-analysis showed that beta-blockers following a myocardial infarction (MI) offer a relatively modest benefit in contemporary practice when ...